146 related articles for article (PubMed ID: 15206653)
1. Choroidal neovascularization after laser in situ keratomileusis in a patient with presumed ocular histoplasmosis syndrome.
Fedorovich I; Mehr DS; Oz O; Akduman L
Eur J Ophthalmol; 2004; 14(3):261-3. PubMed ID: 15206653
[TBL] [Abstract][Full Text] [Related]
2. Choroidal neovascularization after laser
Fedorovich I; Mehr DS; Akduman L
Eur J Ophthalmol; 2004 May - Jun 2004; 14(3):261-263. PubMed ID: 28226176
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy for subfoveal classic choroidal neovascularization related to punctate inner choroidopathy (PIC) or presumed ocular histoplasmosis-like syndrome (POHS-like).
Postelmans L; Pasteels B; Coquelet P; Caspers L; Verougstraete C; Leys A; Wirix M; Mauget-Faÿsse M; Quanranta M; Snyers B; Smets E
Ocul Immunol Inflamm; 2005; 13(5):361-6. PubMed ID: 16419421
[TBL] [Abstract][Full Text] [Related]
4. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.
Sickenberg M; Schmidt-Erfurth U; Miller JW; Pournaras CJ; Zografos L; Piguet B; Donati G; Laqua H; Barbazetto I; Gragoudas ES; Lane AM; Birngruber R; van den Bergh H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
Arch Ophthalmol; 2000 Mar; 118(3):327-36. PubMed ID: 10721954
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study.
Rosenfeld PJ; Saperstein DA; Bressler NM; Reaves TA; Sickenberg M; Rosa RH; Sternberg P; Aaberg TM; Aaberg TM;
Ophthalmology; 2004 Sep; 111(9):1725-33. PubMed ID: 15350329
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series.
Saperstein DA; Rosenfeld PJ; Bressler NM; Rosa RH; Sickenberg M; Sternberg P; Aaberg TM; Aaberg TM; Reaves TA;
Ophthalmology; 2002 Aug; 109(8):1499-505. PubMed ID: 12153802
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy of subfoveal and juxtafoveal choroidal neovascularization in ocular histoplasmosis syndrome: a retrospective case series.
Liu JC; Boldt HC; Folk JC; Gehrs KM
Retina; 2004 Dec; 24(6):863-70. PubMed ID: 15579982
[TBL] [Abstract][Full Text] [Related]
8. Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndrome.
Busquets MA; Shah GK; Wickens J; Callanan D; Blinder KJ; Burgess D; Grand MG; Holekamp NM; Boniuk I; Joseph DP; Thomas MA; Fish E; Bakal J; Hollands H; Sharma S
Retina; 2003 Jun; 23(3):299-306. PubMed ID: 12824828
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy for juxtafoveal choroidal neovascularization due to ocular histoplasmosis syndrome.
Shah GK; Blinder KJ; Hariprasad SM; Thomas MA; Ryan EH; Bakal J; Sharma S
Retina; 2005 Jan; 25(1):26-32. PubMed ID: 15655437
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy with verteporfin for subfoveal choroidal neovascular membranes in highly myopic eyes after laser in situ keratomileusis.
Arevalo JF; Ruiz-Moreno JM; Fernandez CF; Mendoza AJ; Ramirez E; Montero JA
Ophthalmic Surg Lasers Imaging; 2004; 35(1):58-62. PubMed ID: 14750766
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of surgical removal of extensive peripapillary choroidal neovascularization in presumed ocular histoplasmosis syndrome.
Almony A; Thomas MA; Atebara NH; Holekamp NM; Del Priore LV
Ophthalmology; 2008 Mar; 115(3):540-545.e5. PubMed ID: 17988741
[TBL] [Abstract][Full Text] [Related]
12. Surgical removal of extensive peripapillary choroidal neovascularization associated with presumed ocular histoplasmosis syndrome.
Atebara NH; Thomas MA; Holekamp NM; Mandell BA; Del Priore LV
Ophthalmology; 1998 Sep; 105(9):1598-605. PubMed ID: 9754163
[TBL] [Abstract][Full Text] [Related]
13. Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases.
Wachtlin J; Heimann H; Behme T; Foerster MH
Graefes Arch Clin Exp Ophthalmol; 2003 Nov; 241(11):899-906. PubMed ID: 14556077
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab as initial treatment for choroidal neovascularization associated with presumed ocular histoplasmosis syndrome.
Adán A; Navarro M; Casaroli-Marano RP; Ortiz S; Molina JJ
Graefes Arch Clin Exp Ophthalmol; 2007 Dec; 245(12):1873-5. PubMed ID: 17786466
[TBL] [Abstract][Full Text] [Related]
15. Analysis of outcomes for intravitreal bevacizumab in the treatment of choroidal neovascularization secondary to ocular histoplasmosis.
Cionni DA; Lewis SA; Petersen MR; Foster RE; Riemann CD; Sisk RA; Hutchins RK; Miller DM
Ophthalmology; 2012 Feb; 119(2):327-32. PubMed ID: 22133795
[TBL] [Abstract][Full Text] [Related]
16. Verteporfin therapy for CNV secondary to OHS.
Saperstein DA; Rosenfeld PJ; Bressler NM; Rosa RH; Sternberg P; Aaberg TM; Aaberg TM; Weisberger A
Ophthalmology; 2006 Dec; 113(12):2371.e1-3. PubMed ID: 17157140
[No Abstract] [Full Text] [Related]
17. [PDT (photodynamic therapy) treatment of choroidal neovascularisations (CNV) associated with presumed ocular histoplasmosis syndrome (POHS)].
Ringwald A
Klin Monbl Augenheilkd; 2010 Jun; 227(6):507-9. PubMed ID: 20560102
[No Abstract] [Full Text] [Related]
18. Development of early choroidal neovascular membrane in a young myope after LASIK.
Al-Dhibi H; Chaudhry IA; Al-Assiri A; Shamsi FA
Eur J Ophthalmol; 2007; 17(2):262-5. PubMed ID: 17415702
[TBL] [Abstract][Full Text] [Related]
19. [Neovascular membrane and pregnancy. Treatment with bevacizumab].
Gómez Ledesma I; de Santiago Rodríguez MÁ; Follana Neira I; León Garrigosa F
Arch Soc Esp Oftalmol; 2012 Sep; 87(9):297-300. PubMed ID: 22824650
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
